In the HIV+/FIL+ subjects, circulating filaria antigen levels and filaria-specific IgG and IgG4 were lower in at 1 year than at baseline (although this did not achieve significance for the IgG4), suggesting that the treatment was effective in decreasing filarial antigen load.
1
—
—